SH3RF1 Antibody

What is SH3RF1 and why is it important in cellular research?

SH3RF1 (SH3 domain-containing RING finger protein 1), also known as POSH (Plenty of SH3s), is an E3 ubiquitin-protein ligase that plays multiple important roles in cellular signaling and regulation. Research interest in SH3RF1 stems from its involvement in:

• Post-translational regulation of proteins like FAT1

• Acting as a scaffold protein for organizing components of the JNK pathway

• Regulation of T-cell differentiation, particularly promoting T-helper 1 (Th1) differentiation

• Critical functions in neuronal migration during brain development

• Protein sorting at the trans-Golgi network

Understanding SH3RF1 function is valuable for researchers studying developmental disorders, cancer biology, and cellular signaling mechanisms.

What is the structure and domain organization of SH3RF1 protein?

SH3RF1 has a modular structure with distinct functional domains:

This multi-domain structure allows SH3RF1 to both catalyze ubiquitination and act as a scaffold protein that brings together components of signaling pathways, particularly the JNK signaling pathway .

What types of SH3RF1 antibodies are commercially available for research?

Multiple types of SH3RF1 antibodies are available, varying in host species, clonality, and applications:

Most commercially available SH3RF1 antibodies show primary reactivity toward human SH3RF1, though many cross-react with mouse and rat orthologues .

What are the optimal conditions for using SH3RF1 antibodies in Western blot applications?

For optimal Western blot results with SH3RF1 antibodies:

• Sample preparation: Use fresh tissue/cell lysates with protease inhibitors to prevent degradation

• Recommended dilutions:

  • Rabbit polyclonal antibodies: 1:500-1:2000

  • Mouse antibodies: Generally 1:1000-1:5000

• Positive controls: U87-MG cells or mouse brain tissue are recommended

• Protein transfer: Standard PVDF or nitrocellulose membranes work well

• Blocking: 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Primary antibody incubation: Overnight at 4°C in blocking buffer

• Detection system: HRP-conjugated secondary antibodies work well with standard ECL detection

Expected molecular weight of SH3RF1 is approximately 110-120 kDa, though post-translational modifications may affect migration patterns.

How can I optimize immunofluorescence staining with SH3RF1 antibodies?

For successful immunofluorescence detection of SH3RF1:

• Fixation: 4% formaldehyde for 10-15 minutes at room temperature

• Permeabilization: 0.2% Triton X-100 for 5 minutes

• Blocking: 10% normal serum (matching secondary antibody host) for 1 hour

• Antibody dilution: 1:200-1:500 for most polyclonal antibodies

• Incubation: Overnight at 4°C for primary antibody

• Secondary antibody: Alexa Fluor conjugates work well (488, 555, or 647)

• Nuclear counterstaining: DAPI is commonly used

• Mounting: Anti-fade mounting medium to prevent photobleaching

HeLa cells have been successfully used for immunofluorescence validation of SH3RF1 antibodies .

How should I validate an SH3RF1 antibody before using it in critical experiments?

Thorough validation of SH3RF1 antibodies should include:

• Positive and negative controls:

  • Positive: U87-MG cells , HeLa cells , or mouse brain tissue

  • Negative: Cells with SH3RF1 knockdown using siRNA

• Specificity tests:

  • Western blot showing a single band at expected molecular weight

  • Immunoprecipitation followed by mass spectrometry

  • Peptide competition assay using the immunogen peptide

• Cross-reactivity assessment:

  • Test on lysates from multiple species if cross-species reactivity is claimed

  • Check for potential cross-reactivity with other SH3-domain containing proteins

• Application-specific validation:

  • For IF: Colocalization with known interaction partners

  • For IHC: Compare with RNA expression data from the same tissues

This comprehensive validation approach ensures reliable experimental results and minimizes artifacts.

How should I interpret changes in SH3RF1 protein levels in response to experimental treatments?

When analyzing changes in SH3RF1 levels:

• Consider SH3RF1's dual roles:

  • As an E3 ubiquitin ligase affecting target protein stability

  • As a scaffold protein in signaling pathways

• Evaluate in context of known functions:

  • Increased SH3RF1 may indicate enhanced ubiquitination activity

  • Changes may reflect altered JNK pathway activation

  • Consider impact on known targets like FAT1

• Look for concurrent changes:

  • Monitor levels of known SH3RF1 targets (e.g., FAT1)

  • Assess activation status of JNK pathway components

  • Check subcellular localization changes, not just total protein levels

• Methodological considerations:

  • Normalize to appropriate loading controls

  • Use multiple antibodies targeting different epitopes for confirmation

  • Complement protein analysis with mRNA assessment (qPCR)

Research has shown that SH3RF1 overexpression reduces FAT1 levels, while SH3RF1 knockdown increases and stabilizes FAT1 expression at the cell surface .

What are potential artifacts to be aware of when analyzing SH3RF1 localization?

When performing localization studies of SH3RF1:

• Fixation artifacts:

  • Overfixation can mask epitopes and create false negatives

  • Different fixatives may affect SH3RF1 epitope accessibility differently

• Specificity concerns:

  • SH3RF1 contains SH3 domains that share homology with other proteins

  • Confirm specificity through knockdown controls

• Dynamic localization:

  • SH3RF1 localization may change with cell cycle or stimulation

  • Cell confluence and stress can affect localization patterns

• Background interpretation:

  • SH3RF1 has roles at the trans-Golgi network and in signaling complexes

  • Diffuse cytoplasmic staining may be legitimate rather than background

• Technical considerations:

  • Antibody concentration affects signal-to-noise ratio

  • Secondary antibody cross-reactivity can create false positives

To minimize artifacts, use multiple antibodies targeting different epitopes and complement with biochemical fractionation studies.

What might cause variability in SH3RF1 antibody performance across different cell types?

Variability in SH3RF1 antibody performance can be attributed to:

• Expression level differences:

  • SH3RF1 expression varies across tissues and cell types

  • Low expression may require more sensitive detection methods

• Post-translational modifications:

  • Phosphorylation or ubiquitination may mask antibody epitopes

  • Cell-specific modifications might affect antibody recognition

• Interacting proteins:

  • Cell-type specific protein partners may block antibody binding sites

  • Protein complexes may sequester SH3RF1 in certain cellular compartments

• Isoform expression:

  • Different cell types may express variant isoforms with altered epitopes

  • Antibody may have variable affinity for different isoforms

• Technical factors:

  • Cell-specific fixation/permeabilization requirements

  • Matrix effects from different cell lysate compositions

When working with new cell types, optimize antibody dilution and protocols with appropriate positive controls.

How can SH3RF1 antibodies be used to study protein-protein interactions?

SH3RF1 antibodies can be powerful tools for studying protein-protein interactions through:

• Co-immunoprecipitation (Co-IP):

  • Use SH3RF1 antibodies to pull down SH3RF1 and its interaction partners

  • Western blot for suspected binding partners

  • Critical for confirming interactions identified in yeast two-hybrid screens

• Proximity ligation assay (PLA):

  • Visualize and quantify interactions between SH3RF1 and potential partners

  • Provides spatial information about where interactions occur in cells

• Immunofluorescence colocalization:

  • Double staining with SH3RF1 and partner protein antibodies

  • Quantitative colocalization analysis using appropriate software

• FRET/BRET analysis:

  • When combined with fluorescent protein tagging of potential partners

  • SH3RF1 antibodies can validate expression of constructs

• Application example: SH3RF1 was identified as a binding partner of FAT1 through a yeast two-hybrid screen, and this interaction was confirmed through additional protein interaction studies .

What are the best approaches to study SH3RF1's role in protein ubiquitination?

To investigate SH3RF1's E3 ligase activity:

• In vitro ubiquitination assays:

  • Immunoprecipitate SH3RF1 using specific antibodies

  • Perform reactions with purified E1, E2 enzymes, ubiquitin, and potential substrates

  • Western blot to detect ubiquitinated products

• Cellular ubiquitination assays:

  • Manipulate SH3RF1 levels (overexpression or knockdown)

  • Immunoprecipitate candidate substrates (e.g., FAT1 )

  • Immunoblot for ubiquitin to detect changes in substrate ubiquitination

• Ubiquitin chain-specific analyses:

  • Use antibodies specific for different ubiquitin linkages (K48, K63, etc.)

  • Determine type of ubiquitination mediated by SH3RF1 (degradative vs regulatory)

• RING domain mutant controls:

  • Generate catalytically inactive mutants as negative controls

  • Confirm specificity of observed ubiquitination

Research has shown that SH3RF1 can perform self-ubiquitination in the absence of external substrates and promotes ubiquitination of targets like the potassium channel KCNJ1, enhancing its endocytosis .

How can SH3RF1 antibodies be used to investigate the JNK signaling pathway?

SH3RF1 antibodies facilitate JNK pathway research through:

• Scaffold complex analysis:

  • Immunoprecipitate SH3RF1 to pull down JNK pathway components

  • Western blot for RAC1/RAC2, MAP3K11/MLK3, MAP3K7/TAK1, MAP2K7/MKK7, and MAPK8/JNK1 or MAPK9/JNK2

  • MS analysis to identify novel components of the complex

• Activation state assessment:

  • Compare total SH3RF1 levels with phosphorylated JNK levels

  • Correlate SH3RF1 subcellular localization with JNK activation

• T-cell differentiation studies:

  • Monitor SH3RF1 levels during CD4+ and CD8+ T-cell differentiation

  • Correlate with JNK1/JNK2 activation patterns

• Kinetic analysis of pathway assembly:

  • Use time-course immunoprecipitation after stimulation

  • Track recruitment of pathway components to SH3RF1 scaffold

• Inhibitor studies:

  • Use specific JNK pathway inhibitors and assess impact on SH3RF1 complexes

  • Monitor changes in SH3RF1 localization or post-translational modifications

SH3RF1 acts as a scaffold that coordinates with MAPK8IP1/JIP1 to organize different components of the JNK pathway into a functional multiprotein complex that ensures effective JNK signaling pathway activation .

What techniques can be used to study SH3RF1's interaction with FAT1?

To investigate the SH3RF1-FAT1 interaction identified in yeast two-hybrid screens :

• Binding domain mapping:

  • Use antibodies against different regions of SH3RF1

  • Perform co-IP with truncated FAT1 constructs to identify minimal binding regions

• Functional significance assessment:

  • Monitor FAT1 levels after SH3RF1 knockdown or overexpression

  • Track FAT1 surface expression and stability

  • Assess ubiquitination status of FAT1 in response to SH3RF1 manipulation

• Live cell imaging:

  • Use fluorescently tagged proteins and antibody validation

  • Monitor dynamics of interaction in living cells

• In vitro interaction studies:

  • Purify recombinant domains and perform pull-down assays

  • Validate with antibodies against both proteins

• Structure-based analyses:

  • Use information about the juxtamembrane region of FAT1's cytoplasmic tail

  • Design mutation studies to disrupt specific interaction points

Research has demonstrated that SH3RF1 acts as a negative post-translational regulator of FAT1 levels, with SH3RF1 knockdown increasing FAT1 protein levels and stabilizing its expression at the cell surface .

How can SH3RF1 antibodies be used in studies of neuronal development and migration?

For investigating SH3RF1's role in neuronal development:

• Immunohistochemistry of developing brain:

  • Track SH3RF1 expression patterns during cortical development

  • Co-stain with markers of migrating neurons

• Primary neuronal culture studies:

  • Use SH3RF1 antibodies to monitor expression in developing neurons

  • Correlate with formation of proximal cytoplasmic dilation in the leading process

• Ex vivo brain slice experiments:

  • Manipulate SH3RF1 levels and track neuronal migration

  • Immunostain for SH3RF1 and migration markers

• Biochemical fractionation:

  • Separate neuronal subcellular compartments

  • Determine SH3RF1 localization during different migration stages

• Co-IP from developing brain tissue:

  • Identify neuronal-specific SH3RF1 binding partners

  • Compare complexes at different developmental stages

SH3RF1 plays a crucial role in the migration of neocortical neurons in the developing brain and controls proper cortical neuronal migration and the formation of proximal cytoplasmic dilation in the leading process .

What are emerging methods for studying SH3RF1 protein interactions beyond traditional antibody approaches?

Beyond conventional antibody techniques, cutting-edge approaches include:

• Proximity-dependent biotinylation (BioID or TurboID):

  • Fuse SH3RF1 to biotin ligase

  • Identify neighboring proteins through streptavidin pulldown

  • Validate with antibodies against SH3RF1 and identified proteins

• CRISPR-based tagging:

  • Endogenously tag SH3RF1 with fluorescent proteins or epitope tags

  • Combine with specific antibodies for more sensitive detection

• Protein complementation assays:

  • Split fluorescent proteins or enzymes fused to SH3RF1 and potential partners

  • Validate expression using specific antibodies

• Mass spectrometry-based interactomics:

  • Immunoprecipitate SH3RF1 under various conditions

  • Identify interaction partners through quantitative proteomics

  • Compare to approaches like the fusion protein strategy demonstrated with Neffin

• Single-molecule imaging:

  • Use highly specific antibodies for super-resolution microscopy

  • Track individual SH3RF1 molecules and their interactions

These emerging approaches can provide deeper insights into SH3RF1 biology while still utilizing antibodies for validation and complementary analyses.